Robert Rollins has extensive expertise in the fields of cancer epigenetics and oncology, with a career spanning over two decades. Rollins began at Yale University School of Medicine as a Scientific Technician, contributing to molecular biology and biochemical genetics. Following this, a role as a Postdoctoral Research Fellow at Columbia University focused on cancer epigenetics under Dr. Timothy Bestor. Subsequent positions included various scientist roles at Wyeth Research and Pfizer, culminating in a Senior Director position in Oncology Scientific Strategy & External Evaluation at Pfizer since 2020. Additionally, Rollins has experience in product development at Enzo Life Sciences, Inc. and holds a Bachelor’s Degree in Biology from Colgate University and a Ph.D. in Molecular Biology and Genetics from Weill Cornell Graduate School of Medical Sciences.
This person is not in any teams
This person is not in any offices